{"id":229609,"date":"2026-09-03T14:34:35","date_gmt":"2026-09-03T09:04:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=229609"},"modified":"2026-09-03T14:34:37","modified_gmt":"2026-09-03T09:04:37","slug":"onesource-specialty-pharma-share-bull-case-vs-bear-case-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/onesource-specialty-pharma-share-bull-case-vs-bear-case-2026\/","title":{"rendered":"Onesource Specialty Pharma Share: Bull Case vs Bear Case for 2026"},"content":{"rendered":"
<\/div>\n

Onesource Specialty Pharma CMP Rs 1,593.00 on 3 Sep 2026. 52W High Rs 1,925.00, Low Rs 1,057.00. PE not meaningful (loss making) vs sector 37.95. RSI 57.04.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Onesource Specialty Pharma bull case for 2026 points toward the stock retesting its 52 week high of Rs 1,925.00, built on the strengths discussed below. The Onesource Specialty Pharma bear case points toward a slide back near its 52 week low of Rs 1,057.00 if the risks play out instead. The stock currently trades at Rs 1,593.00, with a loss making bottom line, so the industry average PE of 37.95 is the reference point for any future re-rating. The next two quarters of earnings and sector data will likely decide which case plays out.<\/p>\n<\/div>\n

The Onesource Specialty Pharma bull case is under the spotlight as investors weigh Onesource Specialty Pharma’s recent price action against its underlying fundamentals. The stock trades at Rs 1,593.00, against a 52 week high of Rs 1,925.00 and a 52 week low of Rs 1,057.00, leaving room for both the Onesource Specialty Pharma bull case and the Onesource Specialty Pharma bear case to find support in the data.<\/p>\n

Onesource Specialty Pharma operates in the CDMO and Specialty Pharma space, and its return on equity of -1.10 percent and debt to equity ratio of 0.26 form the backbone of the fundamental picture. This article lays out the full Onesource Specialty Pharma bull case and bear case, the data behind each scenario, and the catalysts that could tip the balance one way or the other.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n